| | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2023 ( Subtotal = $494,405 ) |
| 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 4 | 5/4/2023 | NON-COMPETING CONTINUATION | $494,405 |
|
| Issue Date FY: 2022 ( Subtotal = $926,655 ) |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 3 | 8/23/2022 | SUPPLEMENT FOR EXPANSION | $432,250 |
| 2022 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 3 | 5/10/2022 | NON-COMPETING CONTINUATION | $494,405 |
|
| Issue Date FY: 2021 ( Subtotal = $961,993 ) |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 001 | 2 | 4/23/2021 | SUPPLEMENT FOR EXPANSION | $437,500 |
| 2021 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 2 | 4/22/2021 | NON-COMPETING CONTINUATION | $524,493 |
|
| Issue Date FY: 2020 ( Subtotal = $557,534 ) |
| 2020 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215 | SUFFOLK | USA | Diabetes, Digestive, and Kidney Diseases Extramural Research | 000 | 1 | 4/23/2020 | NEW | $557,534 |
|
|